Una Ryan

The Angels' Forum Management Co LLC (The Angels' Forum) is a venture capital firm founded in 1997 by Carol Sands, Craig Sirnio and Alejandro Estrada. The firm is headquartered in Mountain View, California.

Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA.

Golden Seeds LLC (Golden Seeds) is a venture capital firm founded in 2005 by Stephanie Hanbury-Brown. The firm is headquartered in New York city with an additional offices in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, New York and Silicon Valley.

New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Management Sciences for Health, Inc. provides healthcare services. The company was founded by Ronald O’Connor in 1971 and is headquartered in Medford, MA.

IQuum, Inc. designs and develops biological molecular diagnostics products. It develops lab-in-a-tube technology, a novel biological sample testing platform which provides revolutionary benefits to a broad cross section of the bioassay market. The firm''s proprietary technology enables the non-specialized personnel to perform more sophisticated biological sample testing in any setting with greater speed. The company was founded by Shuqi Chen and Keith Greenfield in 1998 and is headquartered in Marlborough, MA.

Cambridge in America provides alumni network relations services. They help build a community of Cambridge University alumni and friends throughout the United States. The company was founded in 2000 and is headquartered in New York, NY.

Lionheart Ventures Fund invests in profitable middle-market industrial & technology companies located in the US. The fund focuses on companies with an EBITDA of $1 - $10 million, revenues of $5 - $50 million and strong management team. It targets companies operating in the fields of niche industrial manufacturers, engineered product companies, sensors & controls, precision mechanical components, automotive, aerospace/defense, pumps, valves & mixers and other general industrial markets. It provides financing for acquisitions, add-on acquisitions and turnaround situations.

Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA.

MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA.

Bioarray Genetics, Inc. develops a patent-pending chemotherapy response assay to help guide physicians in the selection of the most effective treatments. It also develops proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used. The company was founded by Marcia Fournier and Katherine J. Martin in 2009 and is headquartered in Farmington, CT.

Astia Angels (Astia Angels) is a venture capital subsidiary of Astia, Inc, founded in 2013. The firm is headquartered in San Francisco, California.

Elemental Machines, Inc. provide intelligent technology for the smart lab. Its products include synthetic biology, drug discovery, genomic testing and materials sciences. The company was founded by Sridhar Iyengar, Elicia Wong and Gary Tsai in 2014 and is headquartered in Cambridge, MA.

Breakout Ventures LP seeks investment opportunities in companies located in the US. The fund targets the companies operating in the fields of technology, biology, materials and energy. It provides financing for early stage capital requirement.